Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.25 (3.448%)
Open: 7.375
High: 7.375
Low: 7.375
Prev. Close: 7.375
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IXICO plc announces SBRI Healthcare contract

16 Apr 2014 07:00

RNS Number : 9231E
IXICO plc
16 April 2014
 



16 April 2014

 

 

IXICO plc announces SBRI Healthcare development contract

 

IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, announces that it has been awarded a development contract by SBRI Healthcare (The Small Business Research Initiative for Healthcare) to cover Phase 1 funding for the development of an online application designed to support dementia sufferers post-diagnosis.

Receiving a dementia diagnosis is inevitably traumatic for patients and far too often, patients and their families receive very little support until there is a crisis. This development project will build on Assessa™, IXICO's digital healthcare platform to support dementia diagnosis, to address post-diagnostic care planning and support. It aims to harness web and mobile technologies to provide ongoing support and to assist those living with dementia as well as their families, carers and healthcare professionals. The goal is to prolong and enhance independent living by facilitating improved self-care with full interaction with the relevant healthcare professionals and other support agencies. Social media concepts will be adapted to build a personal management tool whereby diagnosis is carefully linked to continuing care-planning and support. This will then aid the transition into other care settings by travelling with the patient and relatives throughout the course of the illness.

The project will be led by IXICO in partnership with the Health Innovation Network South London. (www.hin-southlondon.org)

Commenting on the award, Derek Hill, CEO of IXICO said:

 

'We are delighted to receive this support from SBRI Healthcare which will help us to extend the potential patient benefit of Assessa™ following diagnosis and is central to the widening of our digital healthcare offering. We look forward to working with the Health Innovation Network to improve the care of dementia sufferers.'

 

Commenting on the award, Dr Hugo DeWaal, Clinical Director for Dementia at the Health Innovation Network said:

 

'Dementia is a key health and social care priority, and the Health Innovation Network is keen to develop a tool that is helpful for people with dementia, their families and carers. We hope that this partnership and SBRI funding will allow us to rapidly improve dementia care for a greater number of people.'

About SBRI Healthcare

The Small Business Research Initiative for Healthcare (SBRI Healthcare) is an NHS England initiative, championed by the newly formed Academic Health Science Networks (AHSNs), that aim to promote UK economic growth whilst addressing unmet health needs and enhancing the take up of known best practice. Part of Innovation Health and Wealth, the SBRI Healthcare programme sets industry the challenge in a series of health related competitions which result in fully funded development contracts between the awarded company and the NHS. Unlike many R&D projects which offer grant or match funding, SBRI contracts are 100 per cent funded and the company retains the IP.

More information is available on www.sbrihealthcare.co.uk

About IXICO

IXICO, the brain health company, was founded in 2004 with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products targeting the expanding area of imaging to inform decision-making during drug development. This has resulted in commercially successful products being launched in the clinical trials (Phase 0-III) and experimental medicine markets and more recently launched into the wider clinical diagnostic market. Since incorporation, IXICO has been awarded contracts by nine of the top 15 global pharmaceutical companies as well as leading biotechnology companies. In October 2013, IXICO plc was admitted to trading on AIM. More information is available on www.ixico.com

About the Health Innovation Network

The Health Innovation Network is a membership organisation, driving lasting improvements in health and wellbeing across South London by sharing innovations across the health system and capitalising on teaching and research strengths. Founded by NHS England, the Health Innovation Network is the Academic Health Science Network (AHSN) for South London. We are focusing on health priorities for our local communities across a number of clinical areas and cross-cutting innovation themes, including dementia, diabetes, musculoskeletal, alcohol and cancer. www.hin-southlondon.org 

 

Enquiries:

 

IXICO plc

Derek Hill, CEO

Charles Spicer, VP Corporate Development

+44 20 7691 2064

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Clare Terlouw

+44 20 7418 8900

 

Daniel Stewart & Company (Joint Broker)

Mark Treharne

David Hart

+44 207 776 6550

 

FTI Consulting Limited (Investor Relations)

Ben Atwell

Simon Conway

John Dineen

+44 20 3727 1000 

 

Health Innovation Network

Anna King, Commercial Director

+44 20 7188 7188

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFDEDIFLSEFL
Date   Source Headline
30th Apr 20157:49 amRNSLaunch of dementia care digital platform
24th Apr 20157:00 amRNSNew contract in Huntington's disease
11th Mar 20157:00 amRNSVirtualScopics, IXICO and Micron in collaboration
6th Mar 201511:38 amRNSResult of AGM
10th Feb 20154:25 pmRNSReplacement - Financial Results
10th Feb 20157:00 amRNSResults for the 16 month period ended 30 Sept 2014
16th Jan 20157:00 amRNSIXICO selected as EPAD imaging analysis partner
16th Dec 20147:00 amRNSLicense of TrialTracker to VirtualScopics
26th Nov 20147:00 amRNSAnnouncement of enhanced contracts
29th Oct 20147:30 amRNSGrant of Awards to Directors
17th Sep 20147:00 amRNSAppointment of Chief Financial Officer
7th Aug 20147:00 amRNSAdditional Listing
31st Jul 20144:19 pmRNSHolding(s) in Company
21st Jul 20144:33 pmRNSDirector/PDMR Shareholding
18th Jul 20147:00 amRNSTrading Update
19th Jun 20147:00 amRNSCollaboration with the MRC for dementia research
6th Jun 20147:00 amRNSHalf Yearly Report
22nd May 20147:00 amRNSTwo contracts in Huntington's disease awarded
30th Apr 20142:58 pmRNSHolding(s) in Company
16th Apr 20147:00 amRNSIXICO plc announces SBRI Healthcare contract
20th Mar 201412:41 pmRNSResults of AGM
11th Mar 20142:43 pmRNSDirector/PDMR Shareholding
11th Mar 201410:04 amRNSHolding(s) in Company
7th Mar 20142:35 pmRNSInternational alliance with VirtualScopics
28th Feb 20147:00 amRNSPublication of annual report and business update
6th Feb 20147:00 amRNSAppointment of Joint Broker
13th Jan 20149:51 amRNSPresents at Dementia Challenge seminar in Beijing
2nd Jan 20145:08 pmRNSHolding(s) in Company
17th Dec 20137:00 amRNSBusiness and trading update
13th Dec 20137:00 amRNSTSB Grant to Develop Dementia Diagnosis Products
11th Dec 20137:00 amRNSDementia diagnosis tool launch and InHealth update
10th Dec 20137:00 amRNSAttending G8 Global CEO Initiative on Alzheimer's
2nd Dec 201310:03 amRNSIXICO signs MOU with Beijing UMP
18th Nov 20136:00 pmRNSDirector/PDMR Shareholding
1st Nov 20134:01 pmRNSDirector/PDMR Shareholding
31st Oct 201311:26 amRNSDirector/PDMR Shareholding
22nd Oct 201312:29 pmRNSHolding(s) in Company
21st Oct 20131:22 pmRNSDirector/PDMR Shareholding
17th Oct 20133:08 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSFirst Day of Dealings
14th Oct 201312:18 pmRNSResult of General Meeting
14th Oct 201311:08 amRNSSchedule 1 update - Phytopharm Plc
11th Oct 20131:48 pmRNSSch 1 Update - Phytopharm plc
3rd Oct 20139:23 amRNSHolding(s) in Company
1st Oct 20137:00 amRNSDirector/PDMR Shareholding
30th Sep 20132:45 pmRNSSchedule 1 - Phytopharm Plc
27th Sep 20133:17 pmRNSDirector/PDMR Shareholding
24th Sep 20137:30 amRNSRestoration - Phytopharm Plc
23rd Sep 20137:05 amRNSIXICO expands into digital healthcare
23rd Sep 20137:00 amRNSProposed acquisition of IXICO Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.